教授
石松林
发布时间: 2026年03月02日浏览次数:


石松林
厦门大学,医学院,教授,博士生导师。
《细胞生物学》课程组及《生命基础
-细胞与组织》课程组负责人


研究方向:肝纤维化与肝癌机制与药物靶点

所在系部:基础医学部

办公电话:0592-21886336

邮    箱:shsonglin@xmu.edu.cn

           


研究领域:

1.肝癌等恶性肿瘤的机制研究、药物研发与细胞基因治疗;

2.纤维化疾病(聚焦肝纤维化)的机制研究及药物研发;


教育经历:  

1.2001/09–2007/06, 厦门大学,细胞生物学,博士

2.1993/09–1997/07, 安徽大学,微生物,学士   

科研与学术工作经历:

1.2025/09-至今,厦门大学,医学院,教授

2.2012/08-2025/08,厦门大学,医学院,副教授

3.2014/05-2015/05,美国宾夕法尼亚大学,医学院,访问学者

3. 2009/08-2012/08,厦门大学,医学院,助理教授

4. 2007/07-2009/07,厦门大学化学化工学院,博士后


主持或参加科研项目情况(按时间倒序排序):

1.主持各级基金课题:

(1)国家自然科学基金面上项目《核磷蛋白NPM通过肝枯否细胞的lncRNA-MIAT/TGF-β2作用轴激活肝星状细胞而促进肝纤维化的作用与机制》(2025-2028,编号:82470639;49万元;在研)

(2)翔安创新实验室项目《研发治疗肝纤维化的创新活细胞药物--靶向肝星状细胞的双靶点“与”门控CAR-T/CAR-NK细胞》(2024.01-2025.12,编号:2023XAKJ0102047,10万元;在研)

(3)福建省社会发展引导性(重点)项目《白血病特异性NPM1c+突变蛋白的纳米抗体制备及化学发光检测技术的建立》(编号:2021Y0001;2021-10 至 2024-09,15万元,结题)

(4)国家自然科学基金面上项目《核磷蛋白Nucleophosmin(NPM)在肝硬化进程中的作用与分子机制研究》(2017-2020,编号:81670542;60万元,结题)

(5)国家自然科学基金面上项目《HnRNPA2/B1 在乳腺癌细胞中的作用及分子机制》(2013.01-2016.12,编号:81272921;70万元,已结题)

(6)福建省卫生教育联合攻关项目《核磷蛋白NPM表达与定位异常在肝细胞癌变中作用研究》(2014-2016,编号:WKJ-FJ-16. 合作单位主持人,30万元,已结题)

(7)省自然科学基金《Prohibitin在肿瘤细胞诱导分化中的表达与定位变化及其蛋白相互作用研究》(2008-2010,编号:2008J0302;1.5万元,已结题)

(8)省自然科学基金《核基质蛋白PHB与肿瘤细胞癌变与逆转关系研究》(2011.04-2014.03,编号:2011J01256; 4万元,已结题);

(9)中央高校基本科研业务费项目《HnRNP A2/B1在人肝癌细胞癌变与逆转过程中调控机理研究》(2011-2013,编号:2011121061;20万元,已结题)。

(10)博士后科学基金《一种新核基质蛋白Prohibitin在肿瘤细胞分化中表达与定位变化及其蛋白相互作用研究》(2007-2009,编号:20070420754;3万元,已结题);

2. 作为第一参与人承担的国家自然科学基金项目:

(1)重大研究计划培育项目《炎症微环境刺激肝癌发生与发展的关键调控分子的研究》(2011-2013,编号:91029729,60万元,已结题);

(2)国家自然科学基金面上项目《Nucleophosmin 蛋白修饰变化在肿瘤细胞增殖分化与凋亡调控中的作用机制研究》(2012-2016,81272245,70万元,已结题);

(3)国家自然科学基金面上项目《Nucleophosmin(NPM)在核基质定位及其在肿瘤细胞增殖与分化调控中的作用研究》(2009-2011,编号:30871241,31万元,已结题);

研究论文:

1. 通讯作者论文

(1)Yijian Zhou1,2†, Zhuo Wang1,2†, Hongzhou Zhao1,2†, Yongpan Liu3, Yong Lin4, Jiaying Zhang1,2, Xinxin Li1,2,Bo Zhang1,2, Jialing Xie1,2, Xiaolu An1,2, Lijia Zhang1,2, Songlin Shi2*, Kun Zhang2,5* and Kuancan Liu1,2*. Chelerythrine inhibits esophageal squamous cell carcinoma progression via PINK1-Parkinmediated mitophagy. Journal of Translational Medicine (2025) 23:1116.

(2)Yuan-Rong Zheng, Chao-Jie Wang, Ling Yang, Yu-Jun Zhang, Mei-Juan Fang, He Chang*, Kai-Qiang* Guo, Song-Lin Shi*. Screening of small molecule compounds targeting hnRNPA2 protein. Med Chem Res 32, 2562–2573 (2023).

(3)Yunyun Chen#, Kun Zhang#, Rui ZhangZhuo WangLiang YangTingting ZhaoShihui ZhangYong LinHongzhou ZhaoYongpan LiuYuxuan WeiYijian ZhouJiaying ZhangXianzong YeJing ZhaoXinxin LiJianwen QueSonglin Shi*, Kuancan Liu*. Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma. Cell Death Discov. 9, 399 (2023).

(4)Ding X#, Zhu XL#, Xu DH#, Li S#, Yang Q#, Feng X, Wei YG, Li H, Yang L, Zhang YJ, Deng XL, Liu KC*, Shi SL*. NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2. Cell Death Dis. 2023 Aug 30;14(8):575. (中科院一区TOP)

(5)Dan Wang, Yin Li, Yanling Liu, Shuyu Cheng, FanLiu, Renjie Zuo, Chenchun Ding, Songlin Shi* and Guoyan Liu*, NPM1 promotes cell proliferation by targeting PRDX6 in colorectal cancer, International Journal of Biochemistry and Cell Biology, 2022, 147 ,106233

(6)Li-Bin Gao, Xin-Le Zhu, Ling Yang, Zhen-Qiang Xu, Song-Lin Shi*, HnRNPA2B1 promotes the proliferation of breast cancer MCF-7 cells via STAT3 pathway. Journal of Cellular Biochemistry, 2021;122:472–484. DOI: 10.1002/jcb.29875

(7)Liu Y, Shi S-L*. The roles of hnRNP A2/B1 in RNA biology and disease (Invited review). WIREs RNA. 2020; 12(2):e1612. https://doi.org/10.1002/wrna.1612

(8)Yu Liu#, Huan Li#,Fan Liu#, Li-Bin Gao#, Rong Han#, Chen Chen, Xue Ding, Shuang Li, Kun Lu, Ling Yang, Hui-Min Tian,Bin-Bin Chen,Xiao Li, Dong-Hui Xu, Xiao-Ling Deng, Song-Lin Shi*. Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways. Ebiomedicine 2020, Volume 51, 102583. (中科院一区,TOP)

(9)Yuling Hong#, Haifeng Qin#, Yin Li#, Yuhai Zhang, Xunrong Zhuang, Lei Liu, Kun Lu, Long Li, Xiaoling Deng, Fan Liu, Fan Liu*, Songlin Shi*, Guoyan Liu*. FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E‐cadherin and CD44 expression. J Cell Physiol. 2019;234(11):19895-19910.  

(10)Kun Lu, Gang Rui, Fan Liu, Ling Yang, Xiao-Ling Deng Song-Lin Shi* and Qi-Fu Li*. 14‑3‑3ε is a nuclear matrix protein, and its altered expression and localization are associated with curcumin‑induced apoptosis of MG‑63 cells. Oncology Letters, 2018,15: 338-346.

(11)Li-Chun Zheng #, Xiao-Qing Wang #, Kun Lu #, Xiao-Ling Deng, Cheng-Wei Zhang, Hong Luo, Xu-Dong Xu, Xiao-Man Chen, Lu Yan, Yi-Qing Wang*, Song-Lin Shi*. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells. Oncotarget, 2017, Jun 20; 8(25): 41348–41363. 

(12)Guo-Yan Liu#, Jing-Xian Shi#, Song-Lin Shi#,*,Fan Liu, Gang Rui, Xiao Li, Li-Bin Gao,Xiao-Ling Deng and Qi-Fu Li*. Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6. Journal of Cellular Biochemistry, 2017, 118:4697–4707.

(13)Xiao Li #Dong-Hui Xu #Fan Liu #Guo-Yan Liu,  Kun Lu, Xiao-Ling Deng Qi-Fu Li *, Song-Lin Shi*. Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells. Journal of Cellular Biochemistry [2017], 118:3225–3236

(14)Kun Lu#,Guoyan Liu#, Ling Yang#, Fan Liu,Libin Gao, Jingxian Shi, Xiaoling Deng, Qifu Li, Donghui Xu, Songlin Shi*. Sustainable inflammation transforms hepatic cells by causing oxidative stress injury and potential epithelial-mesenchymal transition. International Journal of Oncology,2016, 49: 971–980.  

(15)Bo Peng#, Fan Liu#, Rong Han#, George Luo, Terry Cathopoulis, Kun Lu, Xiao Li, Ling Yang, Guo-Yan Liu, Jian-Chun Cai*, Song-Lin Shi*. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. The International Journal of Biochemistry & Cell Biology, 2015,66:45–58.

(16)Dong-Hui Xu#, Fan Liu#, Xiao Li, Xiang-Feng Chen, Guang-Jun Jing, Fu-Yun Wu, Song-Lin Shi*, Qi-Fu Li*. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells. International Journal of Oncology, 2014, 45: 264–272.

(17)刘凡(#),陈兰英,黄建,刘用金,石松林(*),热休克蛋白70在人食管癌EC9706细胞凋亡过程中的表达与定位变化,解剖学报,2012,43(04):490-499。

2. 第一作者论文

(1)石松林,赵振利,王国红,刘凡,路锟,杨玲,韩荣,李晓,李祺福(*),Prohibitin在姜黄素诱导人成骨肉瘤MG-63细胞凋亡过程中的调控机制,解剖学报,2015,46(01):72-80。

(2)石松林,陈兰英,刘用金,杨海波,路锟,杨玲,李祺福(*),姜黄素诱导人 食管癌EC9706细胞凋亡过程中核磷蛋白的表达与定位变化,解剖学报,2014,45(02):224-230。

(3)Liang, Ying (#), Shi, Song-Lin(#), Li, Qi-Fu (*) ,Chen, Lan-Ying,Jing, Guang-Jun,Tan, Guo-Wei,Wang, San-Ying,Wu, Fu-Yun,The Localization of hnRNP A2/B1 in Nuclear Matrix and the Aberrant Expression During the RA-Induced Differentiation of Human Neuroblastoma SK-N-SH Cells,Journal of Cellular Biochemistry,2011,112(7):1722-1729。

(4)Shi, Song-Lin(#),Dan, Bing(#) ,Liu, Fan(#),Lin, Li-Rong,Fu, Zuo-Gen,Jing, Guang-Jun,Yang, Tian-Ci(*),Zhang, Zhong-Ying(*),Synthesis and characterization of a novel cationic polymer gene delivery vector,International Journal of Molecular Medicine,2010,26(4):491-500。

(5)Shi, Song-Lin(#) ,Liang, Ying,Li, Qi-Fu(*) ,Liu, Qing-Rong,Jing, Guang-Jun,Wang, San-Ying,Zhang, Xiu-Yan,Wu, Fu-Yun,Localization of Nucleophosmin in Nuclear Matrix and Changes in Its Expression During the Differentiation of Human Neuroblastoma Induced by Retinoic Acid,Journal of Cellular Biochemistry,2010,111(1):67-74。

(6)Shi, Song-Lin(#) ,Li, Qi-Fu(*) ,Liu, Qing-Rong,Xu, Dong-Hui,Tang, Jian,Liang, Ying,Zhao, Zhen-Li,Yang, Li-Ming,Nuclear Matrix Protein, Prohibitin, Was Down-Regulated and Translocated From Nucleus to Cytoplasm During the Differentiation of Osteosarcoma MG-63 Cells Induced by Ginsenoside Rg1. Cinnamic acid, and Tanshinone IIA (RCT),Journal of Cellular Biochemistry,2009,108(4):926-934。

(7)石松林(#),李祺福(*),王国红,马宗源,史建陆,林昌健,人参皂甙Rg1对人成骨肉瘤MG-63细胞形态结构和终末分化指标的影响,厦门大学学报(自然科学版),2009,48(03):392-398。

(8)石松林,黄晓明,李祺福(*),王三英,杨海波,文昌鱼鳃组织原代培养,海洋科学,2009,33(03):44-48。

(9)石松林,李祺福(*),刘庆榕,许东辉,唐剑,梁盈,人参皂苷Rg1组合诱导人成骨肉瘤MG-63细胞分化过程中Prohibitin的表达与定位变化,中国生物化学与分子生物学报,2008,24(02):180-187。

(10)石松林,王国红,李祺福(*),马宗源,林昌健,赵振利,人参皂甙Rg1、肉桂酸和丹参酮IIA组合对成骨肉瘤MG-63细胞增殖与相关基因表达的影响,细胞生物学杂志,2008,30(06):761-765。

(11)石松林,李祺福(*),郑燕彬,唐剑,陈平,人参皂甙Rg1组合对人成骨肉瘤MG-63细胞分化过程中核基质构型与蛋白质组成的影响,解剖学报,2008,39(05):670-676。

(12)石松林,王国红,马宗源,史建陆,林昌健,李祺福(*),丹参酮IIA对人成骨肉瘤MG-63细胞形态结构和终末分化指标的影响,现代生物医学进展,2008,8(05):801-805。

(13)Shi, Song-Lin,Wang, Yong-Ye,Liang, Ying,Li, Qi-Fu(*),Effects of tachypiesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823,World Journal of Gastroenterology,2006,12(11):1694-1698。


已授权发明专利:

1. 靶向NPM蛋白的肽适配子及其多肽药物和应用,授权时间:2024年9月20;专利号:ZL202211301518.X;发明人:石松林,朱新乐,冯娴,刘宽灿,杨玲

  

      

Top